Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Persistence and Adherence to Low-Dose Aspirin for Primary and Secondary Prevention of Cardiovascular DiseasE Using OHDSI

NCT04097912 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04097912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04097912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Persistence and Adherence to Low-Dose Aspirin for Primary and Secondary Prevention of Cardiovascular DiseasE Using OHDSI
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
September 30, 2019
Completion date
November 15, 2020
Enrollment
99,999 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

angina, ischaemic heart disease, myocardial infarction, stroke (including ischaemic stroke and transient ischaemic attack), unstable angina